SB 2499
Signed
TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
- Tennessee
- Senate
- Introduced Feb 2, 2026
- Session 114
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Tennessee’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
7 actions-
Assigned to General Subcommittee of Senate Commerce and Labor Committee
-
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
-
Placed on Senate Commerce and Labor Committee calendar for 3/10/2026
-
Approved by Delayed Bills Committee
-
Introduced, Passed on First Consideration
-
Filed for introduction
-
Refer to Senate Delayed Bills Committee